Cargando…

Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study

Information on medication utilization among pregnant and postpartum women during the pandemic is lacking. We described the prevalence and patterns of self-reported medication use among pregnant and postpartum women during the third wave of the pandemic (June–August 2021). An online questionnaire was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gerbier, Eva, Favre, Guillaume, Tauqeer, Fatima, Winterfeld, Ursula, Stojanov, Milos, Oliver, Alison, Passier, Anneke, Nordeng, Hedvig, Pomar, Léo, Baud, David, Panchaud, Alice, Meyer-Massetti, Carla, Ceulemans, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100043/ https://www.ncbi.nlm.nih.gov/pubmed/35564733 http://dx.doi.org/10.3390/ijerph19095335

Ejemplares similares

Determinants of Vaccination and Willingness to Vaccinate against COVID-19 among Pregnant and Postpartum Women during the Third Wave of the Pandemic: A European Multinational Cross-Sectional Survey
por: Maisonneuve, Emeline, et al.
Publicado: (2023)

SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland
por: Stuckelberger, Sarah, et al.
Publicado: (2021)

Mental health of pregnant and postpartum women during the third wave of the COVID-19 pandemic: a European cross-sectional study
por: Tauqeer, Fatima, et al.
Publicado: (2023)

Mental health status of pregnant and breastfeeding women during the COVID‐19 pandemic—A multinational cross‐sectional study
por: Ceulemans, Michael, et al.
Publicado: (2021)

Current Data on COVID-19 mRNA-Vaccine Safety during Pregnancy Might Be Subject to Selection Bias. Reply to Stroobandt, S.; Stroobandt, R. Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on “Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. Viruses 2021, 13, 1199”
por: Stuckelberger, Sarah, et al.
Publicado: (2021)

Vaccine Willingness and Impact of the COVID-19 Pandemic on Women’s Perinatal Experiences and Practices—A Multinational, Cross-Sectional Study Covering the First Wave of the Pandemic
por: Ceulemans, Michael, et al.
Publicado: (2021)

Self-Reported Medication Use among Pregnant and Breastfeeding Women during the COVID-19 Pandemic: A Cross-Sectional Study in Five European Countries
por: Ceulemans, Michael, et al.
Publicado: (2022)

Déterminants de l’adhésion vaccinale contre la COVID-19 chez les femmes enceintes et en post-partum pendant la troisième vague de la pandémie : une étude transversale multinationale européenne
por: Maisonneuve, E., et al.
Publicado: (2023)

Comment to “Pregnancy and COVID-19, focus on vaccine and pharmacological treatment”
por: Ceulemans, Michael, et al.
Publicado: (2022)

Antidiabetic Medication Utilisation before and during Pregnancy in Switzerland between 2012 and 2019: An Administrative Claim Database from the MAMA Cohort
por: Gerbier, Eva, et al.
Publicado: (2023)

Zika Virus
por: Masmejan, Sophie, et al.
Publicado: (2020)

Mental health in pregnant individuals during the COVID-19 pandemic based on a Swiss online survey
por: Favre, Guillaume, et al.
Publicado: (2022)

Treatment of nausea in pregnancy: a cross-sectional multinational web-based study of pregnant women and new mothers
por: Heitmann, Kristine, et al.
Publicado: (2015)

An international registry for emergent pathogens and pregnancy
por: Panchaud, Alice, et al.
Publicado: (2020)

Association between Antidepressant Treatment during Pregnancy and Postpartum Self-Harm Ideation in Women with Psychiatric Disorders: A Cross-Sectional, Multinational Study
por: Vallee, Jennifer, et al.
Publicado: (2020)

Herbal medicine use in pregnancy: results of a multinational study
por: Kennedy, Deborah A, et al.
Publicado: (2013)

Safety profile of medication used during pregnancy: results of a multinational European study
por: Trønnes, Johanne N., et al.
Publicado: (2017)

Guidelines for pregnant women with suspected SARS-CoV-2 infection
por: Favre, Guillaume, et al.
Publicado: (2020)

Differences in medication beliefs between pregnant women using medication, or not, for chronic diseases: a cross-sectional, multinational, web-based study
por: Roldan Munoz, Sonia, et al.
Publicado: (2020)

COVID-19 in pregnant women – Authors' reply
por: Baud, David, et al.
Publicado: (2020)

Vertical transmission and materno-fetal outcomes in 13 patients with coronavirus disease 2019
por: Masmejan, S., et al.
Publicado: (2020)

Use of Prescribed Drugs to Treat Chronic Diseases during Pregnancy in Outpatient Care in Switzerland between 2014 and 2018: Descriptive Analysis of Swiss Health Care Claims Data
por: Gerbier, Eva, et al.
Publicado: (2022)

Medicines information needs during pregnancy: a multinational comparison
por: Hämeen-Anttila, Katri, et al.
Publicado: (2013)

Postpartum hemorrhage risk is driven by changes in blood composition through pregnancy
por: Robinson, Matthew R., et al.
Publicado: (2021)

Coronavirus disease 2019 during pregnancy: do not underestimate the risk of maternal adverse outcomes
por: Favre, Guillaume, et al.
Publicado: (2020)

Medication use in pregnancy: a cross-sectional, multinational web-based study
por: Lupattelli, A, et al.
Publicado: (2014)

Women's perception of risks of adverse fetal pregnancy outcomes: a large-scale multinational survey
por: Petersen, Irene, et al.
Publicado: (2015)

Maternal-fetal transmission and adverse perinatal outcomes in pregnant women infected with Zika virus: prospective cohort study in French Guiana
por: Pomar, Léo, et al.
Publicado: (2018)

2019-nCoV epidemic: what about pregnancies?
por: Favre, Guillaume, et al.
Publicado: (2020)

Fertility treatment and oral contraceptive discontinuation for identification of pregnancy planning in routinely collected health data – an application to analgesic and antibiotic utilisation
por: Hjorth, Sarah, et al.
Publicado: (2020)

Risk of congenital malformation following first trimester mRNA COVID-19 vaccine exposure in pregnancy: the COVI-PREG prospective cohort
por: Favre, Guillaume, et al.
Publicado: (2023)

Evolution of National Guidelines on Medicines Used to Treat COVID-19 in Pregnancy in 2020–2022: A Scoping Review
por: Maisonneuve, Emeline, et al.
Publicado: (2023)

Perinatal use of triptans and other drugs for migraine—A nationwide drug utilization study
por: Tauqeer, Fatima, et al.
Publicado: (2021)

Prolonged Maternal Zika Viremia as a Marker of Adverse Perinatal Outcomes
por: Pomar, Léo, et al.
Publicado: (2021)

Correction: Absence of Zika virus among pregnant women in Vietnam in 2008
por: Chiu, Y.-C., et al.
Publicado: (2023)

Multiple Information Sources and Consequences of Conflicting Information About Medicine Use During Pregnancy: A Multinational Internet-Based Survey
por: Hämeen-Anttila, Katri, et al.
Publicado: (2014)

Dengue, Zika and chikungunya during pregnancy: pre- and post-travel advice and clinical management
por: Vouga, Manon, et al.
Publicado: (2019)

Use of Decision Support Tools to Empower Pregnant Women: Systematic Review
por: Ngo, Elin, et al.
Publicado: (2020)

COVID-19 mRNA vaccine in pregnancy: Results of the Swiss COVI-PREG registry, an observational prospective cohort study
por: Favre, Guillaume, et al.
Publicado: (2022)

Authors' reply
por: Baud, David, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nnr4geoloeiskbv495kf7e15lu